GM-CSF blockade reduced the expression of GM-CSF downstream genes Ccl6 and Ccl17 (Supplementary Fig. 8f, g), asserting treatment efficacy, and substantially curbed tumor growth (Supplementary Fig. 8h), leading to a significant increase in animal survival (Fig. 8a). The gene discussed is CCL17; the disease is neoplasm.